ArticleThoracic cancer2019

HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.

Feng Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.